Naglazyme
ASB-008
Approved small_molecule completed
Quick answer
Naglazyme for Mucopolysaccharidosis VI is a Approved program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Mucopolysaccharidosis VI
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed